Breathomics as a diagnostic tool for pulmonary embolism

1 Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, de Groot PG. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 7: 1737–40. 2 Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185–90. 3 Miyakis S, LockshinMD, Atsumi T, BranchDW, Brey RL, Cervera R, Derksen RHWM, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J ThrombHaemost 2006; 4: 295–306. 4 Aboud M, Roddie C, Ward C, Coyle L. To mix with pooled normal plasma or not to mix: a comparative study of two approaches to assess lupus anticoagulant inhibitory activity in the dilute Russell Viper venom method. Clin Chem 2007; 53: 143–5. 5 Thom J, Ivey L, Eikelboom J. Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant. J ThrombHaemost 2003; 1: 2689–91. 6 Devreese KMJ. No more mixing tests required for integrated assay systems in the laboratory diagnosis of lupus anticoagulants? J Thromb Haemost 2010; 8: 1120–2. 7 Details of the Royal College of Pathologists of Australasia (RCPA) Haematology Quality Assurance Program (QAP) and test modules. http://www.rcpaqap.com.au/haematology/. Accessed 19 August 2010.

[1]  J. Austin,et al.  Detection of lung cancer using weighted digital analysis of breath biomarkers. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[2]  D. Aujesky,et al.  Differential value of risk factors and clinical signs for diagnosing pulmonary embolism according to age , 2005, Journal of thrombosis and haemostasis : JTH.

[3]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[4]  N. Lewis.  Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors. , 2004, Accounts of chemical research.

[5]  H. Paretzke,et al.  Differences in exhaled gas profiles between patients with type 2 diabetes and healthy controls. , 2010, Diabetes technology & therapeutics.

[6]  Niki Fens,et al.  Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. , 2009, American journal of respiratory and critical care medicine.

[7]  Peter J Sterk,et al.  An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.

[8]  Peter Elsner,et al.  Smelling Renal Dysfunction via Electronic Nose , 2005, Annals of Biomedical Engineering.

[9]  N. Bârsan,et al.  Electronic nose: current status and future trends. , 2008, Chemical reviews.

[10]  David Moher,et al.  The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration , 2003, Annals of Internal Medicine [serial online].

[11]  R. al Dieri,et al.  Monitoring new oral antithrombotics: what we should know before we can decide , 2010, Journal of thrombosis and haemostasis : JTH.

[12]  F. Klok,et al.  Diagnostic management of clinically suspected acute pulmonary embolism , 2009, Journal of thrombosis and haemostasis : JTH.

[13]  Pieter W Kamphuisen,et al.  Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. , 2006, JAMA.

[14]  Douglas B. Kell,et al.  Statistical strategies for avoiding false discoveries in metabolomics and related experiments , 2007, Metabolomics.

[15]  M. Phillips,et al.  Breath markers of oxidative stress in patients with unstable angina. , 2003, Heart disease.